These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 9175037)

  • 1. Vascular access thrombosis--what are the possibilities of intervention?
    Mysliwiec M
    Nephrol Dial Transplant; 1997 May; 12(5):876-8. PubMed ID: 9175037
    [No Abstract]   [Full Text] [Related]  

  • 2. Dialysis: vascular access: not enough light at the end of the tunnel?
    Vanholder R; Verbeke F; Van Biesen W
    Nat Rev Nephrol; 2009 Oct; 5(10):551-2. PubMed ID: 19776771
    [No Abstract]   [Full Text] [Related]  

  • 3. Pharmacologic intervention to prevent hemodialysis vascular access thrombosis.
    Diskin CJ; Stokes TJ; Pennell AT
    Nephron; 1993; 64(1):1-26. PubMed ID: 8502311
    [No Abstract]   [Full Text] [Related]  

  • 4. Coagulation and haemodialysis access thrombosis.
    Smits JH; van der Linden J; Blankestijn PJ; Rabelink TJ
    Nephrol Dial Transplant; 2000 Nov; 15(11):1755-60. PubMed ID: 11071961
    [No Abstract]   [Full Text] [Related]  

  • 5. Is hyperhomocysteinaemia a risk factor for recurrent vascular access thrombosis in haemodialysis patients?
    Ducloux D; Pascal B; Jamali M; Gibey R; Chalopin JM
    Nephrol Dial Transplant; 1997 Sep; 12(9):2037-8. PubMed ID: 9306379
    [No Abstract]   [Full Text] [Related]  

  • 6. Recurrent venous thrombosis associated with permanent internal jugular vein hemodialysis catheters.
    Domoto DT; Garvin PJ
    ASAIO Trans; 1987; 33(3):140-3. PubMed ID: 3675936
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of tunneled-cuffed catheter-related right atrial thrombosis in hemodialysis patients.
    Yang H; Chen F; Jiao H; Luo H; Yu Y; Hong HG; Li Y; Fu P; Cui T
    J Vasc Surg; 2018 Nov; 68(5):1491-1498. PubMed ID: 29804743
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Haemodialysis access: the case for prospective monitoring.
    Smits JH; Blankestijn PJ
    Curr Opin Nephrol Hypertens; 1999 Nov; 8(6):685-90. PubMed ID: 10630814
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Recurrent vascular access trombosis associated with the prothrombin mutation G20210A in a adult patient in haemodialysis].
    Quintana LF; Coll E; Monteagudo I; Collado S; López-Pedret J; Cases A
    Nefrologia; 2005; 25(4):442-4. PubMed ID: 16231514
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stent graft or balloon angioplasty alone for dialysis-access grafts.
    Tokmak F; Krämer BK; Krüger B
    N Engl J Med; 2010 May; 362(20):1939; author reply 1940. PubMed ID: 20496466
    [No Abstract]   [Full Text] [Related]  

  • 11. [Three-and-a-half years' experience with hemodialysis using 37 Permcaths without infection or definitive thrombosis].
    Toulon J; Broyet C; Diab N; Favre JP; Gournier JP; Jurine J; Barral X; Berthoux F
    Nephrologie; 1994; 15(2):95-100. PubMed ID: 7519329
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Should anticoagulants and/or antiplatelet agents be used in patients with frequent access thrombosis but without evident coagulopathy?
    Allon M
    Semin Dial; 2011; 24(4):393-5. PubMed ID: 21801205
    [No Abstract]   [Full Text] [Related]  

  • 13. Pharmacologic intervention to prevent hemodialysis vascular access thrombosis: the next generation of treatment?
    Diskin CJ
    Kidney Int; 2005 Jun; 67(6):2505. PubMed ID: 15882303
    [No Abstract]   [Full Text] [Related]  

  • 14. [Incidence of thrombosis and septicemia during the use of double-lumen polyurethane hemodialysis catheters].
    Wanscher MC; Frifelt JJ; Andersen AP; Smith-Sivertsen C; Sanchez Garcia R
    Ugeskr Laeger; 1987 Apr; 149(18):1190-2. PubMed ID: 3603746
    [No Abstract]   [Full Text] [Related]  

  • 15. Clopidogrel diminishes hemodialysis access graft thrombosis.
    Trimarchi H; Young P; Forrester M; Schropp J; Pereyra H; Freixas E
    Nephron Clin Pract; 2006; 102(3-4):c128-32. PubMed ID: 16282697
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antithrombotic agents and the prevention of access thrombosis.
    Kaufman JS
    Semin Dial; 2000; 13(1):40-6. PubMed ID: 10740671
    [No Abstract]   [Full Text] [Related]  

  • 17. Antiplatelet therapy to prevent hemodialysis vascular access failure: systematic review and meta-analysis.
    Palmer SC; Di Micco L; Razavian M; Craig JC; Ravani P; Perkovic V; Tognoni G; Graziano G; Jardine M; Pellegrini F; Nicolucci A; Webster A; Strippoli GF
    Am J Kidney Dis; 2013 Jan; 61(1):112-22. PubMed ID: 23022428
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyperhomocysteinemia, anticardiolipin antibody status, and risk for vascular access thrombosis in hemodialysis patients.
    Manns BJ; Burgess ED; Parsons HG; Schaefer JP; Hyndman ME; Scott-Douglas NW
    Kidney Int; 1999 Jan; 55(1):315-20. PubMed ID: 9893142
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complications associated with hemodialysis vascular access procedures: the case for a classification.
    Falk A; Wilson SE; Tordoir J; Gallieni M
    J Vasc Access; 2008; 9(1):10-1. PubMed ID: 18379974
    [No Abstract]   [Full Text] [Related]  

  • 20. [Thrombosis of the vascular access in hemodialysis patients. Rationale for the preventive use of olive oil].
    Villarrubia VG; Gil-Cunquero JM; Pérez-Bañasco V
    Nefrologia; 2007; 27(2):122-33. PubMed ID: 17564556
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.